Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice Int Urogynecol J (2017) 28:1351–1356 DOI 10.1007/s00192-017-3271-1 ORIGINAL ARTICLE Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice 1,2 3 4 Linda Collins & Sanchutha Sathiananthamoorthy & Mandy Fader & James Malone-Lee Received: 7 November 2016 /Accepted: 5 January 2017 /Published online: 23 January 2017 The International Urogynecological Association 2017 Abstract CISC prior to injections and continued. None of the 196 pa- Introduction and hypothesis Botulinum toxin has become a tients developed acute retention or significant voiding widely adopted treatment for patients with recalcitrant over- symptoms. active bladder (OAB) symptoms. Some recommend clean in- Conclusions Our study indicates that routine administration termittent self-catheterisation (CISC) if a postvoid residual of CISC based on an arbitrary PVR volume is unlikely to (PVR) >200 ml posttreatment, but there is no evidence for this confer benefit. In order to avoid patients being deterred from recommendation. The aim of this study was to identify wheth- botulinum treatment, we recommend that CISC be reserved er abstinence from CISC as a routine strategy for patients with for those who have troublesome voiding symptoms as well as a PVR following intradetrusor botulinum toxin injections is a raised PVR. It is unlikely that CISC, initiated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urogynecology Journal Springer Journals

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice

Loading next page...
 
/lp/springer_journal/intermittent-catheterisation-after-botulinum-toxin-injections-the-time-4jGRD1048D
Publisher
Springer London
Copyright
Copyright © 2017 by The International Urogynecological Association
Subject
Medicine & Public Health; Gynecology; Urology
ISSN
0937-3462
eISSN
1433-3023
D.O.I.
10.1007/s00192-017-3271-1
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial